Brought to you by
ECR 2013 / C-0702
MSCT in GIST patients with hepatic metastases treated with new generation tyrosinkinase inhibitors: comparison between density and dimension.
Congress: ECR 2013
Poster No.: C-0702
Type: Scientific Exhibit
Keywords: Oncology, Abdomen, Gastrointestinal tract, CT, Contrast agent-intravenous, Staging, Cancer, Metastases, Monoclonal antibodies
Authors: A. Insalaco, G. Lo Re, F. Muscarneri, F. Patti, M. C. Galfano, L. La Grutta, T. V. Bartolotta, M. Midiri; Palermo/IT
DOI:10.1594/ecr2013/C-0702

References

Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours:   revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228_47

 

Choi H, Charnsangavej C, de Castro FS et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitativeanalysis correlated with FDG PET findings. AJR Am J Roentgenol 2004; 183:1619–1628.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more